Seen plenty of weirdness and questionable trading and share price manipulation in the biotech universe. Those looking for instant gratification may be disappointed if share price does not do an instant blast off. Even with fda approval the short side can suppress share price until they are ready to take their foot off. Astx goes higher with ema and it's not if but when. All IMHO.
It is the fallout from the MP470 news, which is being republished in multiple places, investor sites, blogs, bio-newsletters. Google sends me emails with info on ASTX and the news release has been cited or republished in at least 10 places now.
In an age of amazing access to information, NOT ONE of the articles I saw mentioning the MP 470 stoppage mentioned the HUGE catalyst of the EU AML decision being less than a week away. None said, "hey, if you sell on this news you may miss the boat next week."
By the way, if the share price was tanking today on heavy volume, I would say it may reflect insider info sales and the EU decision. I'm not seeing that.
I believe criminal manipulation of share price is being done. Look at the last two major share price news events. Right before options expiration. What are the odds of that?MP470 just missed with a 9.5 versus 10 response rate on a small sample. Is that reason to walk from a trial and what's left of a 25 million plus clinic and further research investment?